MedTrace Logo

Storage Temperature and Quality of Leucoreduced Whole Blood

NCT01892670 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 87

Last updated 2024-03-19

No results posted yet for this study

Summary

In a combat situation the need for safe and high-quality blood products is increasing. WB (Whole Blood) is used in many trauma situations, but we wish to investigate whether there is an even better whole blood product.

The purpose of this study is to examine the quality of leucoreduced, cold-stored whole blood. We also wish to examine the effects of filtration of whole blood without a 1-2 hour holding-time (warm-filtration) and the effects of forced filtration. We also wish to explore the possibility of using cold-stored WB for production of RCC.

Analyses are performed with a main focus to investigate function and quality of red blood cells and platelets.

Conditions

  • Trauma
  • Austere Environment
  • Blood Bank
  • Buddy Transfusion

Interventions

OTHER

Donation of 1 whole blood unit

Donation of 450-500 mL of whole blood according to local blood bank procedures and national guidelines.

Sponsors & Collaborators

  • Norwegian Armed Forces Medical Service

    collaborator OTHER_GOV

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Geir Strandenes, MD · Haukeland University Hospital and Norwegian Naval Special Operation Commando

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01892670 on ClinicalTrials.gov